Pharmacogenomics and Pharmacoepidemiology
Personalised medicine is a goal that can be accomplished by doctors with the help of pharmacogenomics and pharmacogenomics. The term "personalised medicine" will eventually refer to drugs that are appropriate not just for the proper patient but also for the particular sickness or disease that is affecting that patient. The current state of clinical practise, medication development, and drug regulation provide significant challenges.
Pharmacoepidemiology is the study of how drugs are used and their impact on large populations of individuals. It provides estimates of both the positive and negative effects of drugs on a population. Epidemiology and clinical pharmacology are stated to be combined in it.
Related Conference of Pharmacogenomics and Pharmacoepidemiology
July 25-26, 2024
4th International Conference on Biomedicine & Pharmacotherapy
Prague, Czech Republic
Pharmacogenomics and Pharmacoepidemiology Conference Speakers
Recommended Sessions
- Pharmaceutical manufacturing and Pharmacoeconomics
- Advanced Pharmaceutical Technology
- Bioequivalence and Bioavailability
- Clinical Pharmacy and Pharmacy Practices
- Digital Pharma and Marketing
- Drug Discovery
- Drug Discovery
- Drug Discovery, Design & Development: Challenges and Approaches
- Nano medicine and Biomedical Application
- Novel Drug Delivery Systems, Biomarkers and Drug Targets
- Pharmaceutical Analysis
- Pharmaceutical Care and Health System
- Pharmaceutical Innovation
- Pharmaceutical Innovation
- Pharmaceutical Innovation
- Pharmaceutical Microbiology
- Pharmaceutical Nanotechnology
- Pharmacogenomics and Pharmacoepidemiology
- Pharmacology and Toxicology
- Technology in Pharma Sciences
- The future of Pharma R&D